Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Foghorn Therapeutics Inc. (FHTX)

Codexis, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Codexis, Inc. and Foghorn Therapeutics Inc. are of similar size ($113.1M and $111.7M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against 35.9%. Codexis, Inc. has the higher net margin (−39.6% vs −175.8%) and the lower return on invested capital (−151.2% vs 0.00%). Across the 17 metrics below, Codexis, Inc. leads on 9 and Foghorn Therapeutics Inc. on 8.

Valuation

Metric CDXS FHTX Biotechnology median
P/E n/m n/m 10.60
P/S 1.25 3.60 9.40
P/B 2.96 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.22 0.66
EV/Sales 0.98 (0.42) 9.02
Earnings yield (31.78%) (52.41%) (32.88%)
Free cash flow yield (12.49%) (63.84%) (23.13%)

Profitability

Metric CDXS FHTX Biotechnology median
Gross margin 87.02% 100.00% 68.51%
Operating margin (35.61%) (198.04%) 0.00%
Net margin (39.55%) (175.78%) 0.00%
Free cash flow margin (15.66%) (229.49%) 0.00%
Return on equity (69.36%) 81.90% (51.96%)
Return on assets (23.79%) (30.06%) (46.06%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS FHTX Biotechnology median
Revenue growth (TTM) 35.89% 51.98% 6.76%
EPS growth (last fiscal year) 43.82% 25.32% 29.88%
Revenue growth, 5-year CAGR 0.38% 135.14% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS FHTX Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 3.36 4.97
Net debt to EBITDA 1.11 1.88 1.01

Dividend

Metric CDXS FHTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDXS FHTX Biotechnology median
Market cap 111.70m 113.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack